This is a routine board appointment with no financial data or strategic changes. Monitor next quarterly earnings for any operational updates or guidance changes.
Price Chart
Executive Summary
United Therapeutics appointed Victor Dzau, M.D., former President of the National Academy of Medicine, to its Board of Directors on July 22, 2026. This is a routine board refreshment appointment of a highly credentialed academic and healthcare leader, with no material financial impact or change in corporate strategy disclosed. The filing contains no financial data, guidance, or operational updates.
Key Facts
- Board size increased to 13 members with the appointment of Victor Dzau, M.D.
- Dr. Dzau recently completed a 12-year tenure as President of the National Academy of Medicine.
- Dr. Dzau received initial equity grants of 380 RSUs and 1,190 stock options, plus pro-rata grants of 350 RSUs and 1,110 stock options for the remainder of the 2026-2027 board service year.
- No material transactions between Dr. Dzau and the company exceeding $120,000.
- The appointment is part of a 'concerted Board refreshment effort' as stated by the company.
Financial Impact
No material financial impact. Director equity grants are standard and immaterial relative to a $22.7B market cap.
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-086068 |
| Document: tm2620809d1_ex99-1.htm | 0001104659-26-086068 |
| Document: 0001104659-26-086068-index-headers.html | 0001104659-26-086068 |
| Document: 0001104659-26-086068-index.html | 0001104659-26-086068 |
| Document: 0001104659-26-086068.txt | 0001104659-26-086068 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | Insider Cluster | $500.35 $497.31 | ▼ −0.61% | ▼ −2.72% | $573.51 (+14.62%) |
Sep 11, 2026 21d ago | Insider Cluster | $497.11 $494.63 | ▼ −0.50% | ▼ −0.28% | $573.51 (+15.37%) |
Sep 10, 2026 22d ago | Insider Cluster | $503.86 $497.27 | ▼ −1.31% | ▼ −0.81% | $573.51 (+13.82%) |
Sep 9, 2026 23d ago | Insider Cluster | $506.82 $498.48 | ▼ −1.65% | ▼ −0.99% | $573.51 (+13.16%) |
Sep 4, 2026 28d ago | Insider Cluster | $487.61 $502.70 | ▲ +3.09% | ▲ +4.30% | $573.51 (+17.62%) |
Sep 3, 2026 29d ago | Insider Cluster | $488.16 $497.11 | ▲ +1.83% | ▲ +2.98% | $573.51 (+17.48%) |
Aug 28, 2026 5w ago | Insider Cluster | $515.46 $487.61 | ▼ −5.40% | ▼ −5.51% | $573.51 (+11.26%) |
Aug 27, 2026 5w ago | Insider Cluster | $527.91 $492.02 | ▼ −6.80% | ▼ −6.03% | $573.51 (+8.64%) |
Aug 26, 2026 5w ago | Insider Cluster | $516.68 $492.02 | ▼ −4.77% | ▼ −4.65% | $573.51 (+11.00%) |
Aug 25, 2026 5w ago | Insider Cluster | $516.68 $492.02 | ▼ −4.77% | ▼ −4.65% | $573.51 (+11.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access